ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1406

A Combined Score of Facet Joint Ankylosis and Syndesmophyte Development Correlates Well with Spinal Mobility in Axial Spondyloarthritis

Ana Bento da Silva1, Floris A. van Gaalen1, Robert Landewé2, Manouk de Hooge3, Mary Lucy Marques4, Miranda van Lunteren1, Liese de Bruin1, Gizem Ayan5, Xenofon Baraliakos6, Monique Reijnierse7, Jürgen Braun8, Désirée Van Der Heijde1 and Sofia Ramiro9, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Amsterdam University Medical Center, Amsterdam, Netherlands; and Zuyderland Medical Center, Heerlen, Netherlands, 3Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands; and Coimbra Local Health Unit, Coimbra, Portugal, 5Ankara Research and Training Hospital, Ankara, Turkey, 6Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 7Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 8Ruhr-University, Bochum, Germany; and Rheumatologische Versorgungszentrum (RVZ) Steglitz, Berlin, Germany, 9Leiden University Medical Center, Bunde, Netherlands

Meeting: ACR Convergence 2025

Keywords: Imaging, range of motion, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1405–1433) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: In axial SpA (axSpA), the computed tomography (CT) syndesmophyte score (CTSS) has shown to capture more spinal structural damage progression and to better correlate with spinal mobility than the modified Stoke Ankylosis Spondylitis Spine Score (mSASSS, the current gold standard) (Stal R et al, RMD Open 2023). Recently, a combined score of syndesmophyte and facet joint ankylosis (FJA) development has been proposed as a more sensitive instrument in capturing damage progression. We aimed to assess whether this combined score retains good correlation with spinal mobility compared to current measurement instruments.

Methods: Data from the Sensitive Imaging in Ankylosing Spondylitis cohort were used, including axSpA patients fulfilling the modified New York criteria and with ≥1 syndesmophyte. Conventional radiography (CR) and low-dose computed tomography (ldCT) of the spine were performed at baseline (BL) and scored by 3 (CR) or 2 (ldCT) central readers, blinded for time order. Syndesmophytes were assessed on CR and ldCT by the mSASSS and CTSS, respectively. FJA was evaluated on ldCT with the facet ankylosis score (FAS) on 19 facet joints (levels C5-T2 excluded due to poor visibility, range: 0-38). Three different versions of a combined score of FJA and syndesmophyte development (the CT facet ankylosis syndesmophyte spine score, CTFASSS) were proposed and computed by adding the CTSS and FAS while giving equal weight to both components (CTFASSS-A = CTSS + FAS), 50% more weight to FAS (CTFASSS-B = CTSS + 1.5xFAS) or 100% more weight to FAS (CTFASSS-C = CTSS + 2xFAS). At BL, the following spinal mobility measures were evaluated: occiput-to-wall distance (OWD), lateral spinal flexion (LSF), modified Schober test (mSchober), cervical rotation and chest expansion. The composite score BASMI was calculated. Correlations between each spinal structural damage score and spinal mobility were assessed at BL with Spearman’s rank correlation coefficients and compared. A cumulative probability plot was created to better illustrate correlations between CTFASSS and BASMI.

Results: Forty-six patients had data available for all structural damage scores and spinal mobility measures at BL: mean (SD) age of 47 (9.6) years, 87% male, 83% HLA-B27+. All versions of the CTFASSS showed substantial correlations with OWD (CTFASSS-A: rs 0.65; CTFASSS-B and CTFASSS-C: rs 0.66) and LSF (CTFASSS-A and CTFASSS-B: rs -0.72; CTFASSS-C: rs -0.73) and moderate correlations with the other measures, to a similar degree to that observed for CTSS, but better than mSASSS (Table 1). Notably, compared to mSASSS, FAS alone correlated better with OWD (rs 0.64 vs 0.50) and cervical rotation (rs -0.62 vs -0.49). However, no additional benefit was obtained with a CTFASSS score attributing more weight to FAS compared to the simple sum of the components (i.e. CTFASSS-A). Although substantial correlations were observed between all imaging scores and BASMI, better results were seen with CTSS and CTFASSS (Figure 1).

Conclusion: A composite score assessing syndesmophytes and FJA correlates with spinal mobility similarly well as CTSS but better than mSASSS, supporting the validity of the combined score in assessing spinal damage progression in axSpA.

Supporting image 1Table 1. Spearman’s correlation between spinal structural damage scores and spinal mobility (at baseline, n=46)*

Supporting image 2Figure 1. Cumulative probability plot representing the relationship between BASMI and CTFASSS-A

(BASMI: Bath Ankylosing Spondylitis Metrology Index; CTFASSS-A: Computed Tomography Facet Ankylosis Syndesmophyte Spine Score version A; CTSS: Computed Tomography Syndesmophyte Score; FAS: Facet Ankylosis Score)


Disclosures: A. Bento da Silva: None; F. van Gaalen: AbbVie, 2, BMS, 2, Eli Lilly, 2, Jacobus Stichting, 5, MSD, 2, Novartis, 2, 5, Stichting ASAS, 5, Stichting vrienden van Sole Mio, 5, UCB, 5; R. Landewé: AbbVie/Abbott, 2, Bristol-Myers Squibb(BMS), 2, Eli Lilly, 2, Janssen, 2, Joint Imaging BV, 12, Director, Novartis, 2, Pfizer, 2, Rheumatology Consultancy BV, 12, Director, UCB, 2; M. de Hooge: UCB pharma, 2; M. Marques: Novartis, 2, 6; M. van Lunteren: None; L. de Bruin: None; G. Ayan: None; X. Baraliakos: AbbVie, 2, 5, 6, 12, Paid Instructor, Advanz, 2, 6, 12, Paid instructor, Alexion, 2, 6, 12, Paid instructor, Alphasigma, 2, 6, 12, Paid instructor, Amgen, 2, 6, 12, Paid instructor, BMS, 2, 6, 12, Paid instructor, Celgene, 6, Celltrion, 2, 5, 6, 12, Paid instructor, Cesas, 2, 6, 12, Paid instructor, Chugai, 2, 6, Clarivate, 6, 12, Paid instructor, Galapagos, 2, 6, 12, Paid instructor, J&J, 2, 6, 12, Paid instructor, Janssen, 5, Lilly, 2, 6, 12, Paid instructor, Merck, 6, MoonLake, 2, 5, 6, 12, Paid instructor, MSD, 2, Novartis, 2, 5, 6, 12, Paid instructor, Peervoice, 2, 6, 12, Paid instructor, Pfizer, 2, 6, 12, Paid instructor, Roche, 2, 6, 12, Paid instructor, Sandoz, 2, 6, 12, Paid instructor, Springer, 2, 6, 12, Paid instructor, Stada, 2, 6, 12, Paid instructor, Takeda, 2, 6, 12, Paid instructor, UCB, 2, 6, 12, Paid instructor, Zuellig, 2, 6, 12, Paid instructor; M. Reijnierse: None; J. Braun: None; D. Van Der Heijde: AbbVie, 2, Alfasigma, 2, Annals of the Rheumatic Diseases, 12, Associate editor, ArgenX, 2, Bristol Myers Squibb, 2, Eli Lilly and Company, 2, Grey-Wolf Therapeutics, 2, Imaging Rheumatology BV, 12, Director, Janssen, 2, Journal of Rheumatology, 12, Editorial board member, Novartis, 2, Pfizer, 2, RMD Open, 12, Editoral board member, Takeda, 2, UCB, 2; S. Ramiro: AbbVie, 2, 5, Eli Lilly, 2, 5, Galapagos/Alfasigma, 2, 5, Janssen, 2, MSD, 2, 5, Novartis, 2, 5, Pfizer, 2, 5, Sanofi, 2, 5, UCB, 2, 5.

To cite this abstract in AMA style:

Bento da Silva A, van Gaalen F, Landewé R, de Hooge M, Marques M, van Lunteren M, de Bruin L, Ayan G, Baraliakos X, Reijnierse M, Braun J, Van Der Heijde D, Ramiro S. A Combined Score of Facet Joint Ankylosis and Syndesmophyte Development Correlates Well with Spinal Mobility in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/a-combined-score-of-facet-joint-ankylosis-and-syndesmophyte-development-correlates-well-with-spinal-mobility-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-combined-score-of-facet-joint-ankylosis-and-syndesmophyte-development-correlates-well-with-spinal-mobility-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology